Accordingly, immunoblot analysis of patient LC26 demonstrated the presence, in cancer tissue, of an abnormal MET protein with lower molecular weight that was expressed at increased levels, compared with the MET protein expressed in the corresponding normal tissue of the same patients (Figure 5B). This evidence concerns the gene MET and cancer.